Latest Kaiser Health News Stories
A Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years.
Since gaining control of the House, Senate and governor’s office, Colorado Democrats are pushing an aggressive health care agenda. With measures to create a public insurance option, welcome drug importation, lower drug prices, curtail surprise billing and cap insulin copays, the state is becoming a likely model for health policies at the federal level.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
The California Democratic members of Congress who flipped seven Republican seats two years ago made health care a major campaign issue, criticizing their opponents for voting to repeal the Affordable Care Act. As the Democrats defend their seats in this year’s elections, they are coming back to health care — but the issues are different.
President Donald Trump’s proposed budget includes billions of dollars in health spending cuts, Congress gets back to work on surprise medical bills, and health care remains a top issue for the 2020 Democratic presidential candidates. Rep. Donna Shalala (D-Fla.), a former Health and Human Services secretary, joins the panel at a special taping before a live audience in Washington, D.C. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more.
Happy Friday! In news that is technically really good and exciting but is also kind of icky: yarn made from human skin could eventually be used to stitch up surgical wounds as a way to cut down on detrimental reactions from patients. As CNN reports, “The researchers say their ‘human textile,’ which they developed from […]
We checked again. The data has not changed.
Here’s a sampling of recent fact checks related to some of the health care claims made during President Donald Trump’s Feb. 4 State of the Union speech.
But like all of health care, it’s complicated.
As the Democratic primary campaign nears pivotal voting, important aspects of health care policy are being overlooked.
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
California lawmakers are proposing ambitious health care ideas, from creating a state generic drug label to banning the sale of flavored e-cigarette products. Even though Democrats control state government, they’re likely to face pushback from powerful health care industry groups like hospitals.
Democratic presidential candidates also returned to now-familiar themes in debating the differences between “Medicare for All” and more incremental reforms.
Calculations are complicated, but correct.
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.